Resveratrol triggers protective autophagy through the ceramide/Akt/mTOR pathway in melanoma B16 cells

Nutrition and Cancer

Volumn 66, Issue 3, 2014, Pages 435-440

  Wang, Meng ^a   Yu, Teng ^a   Zhu, Chengyao ^b   Sun, Hui ^a   Qiu, Ying ^a   Zhu, Xia ^c   Li, Jinchao ^d  

^a Shandong Jining No1 People's Hospital   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c Department of Ophthalmology   (China)

^d SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; BECLIN 1; CERAMIDE; FUMONISIN B1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; RESVERATROL; SMALL INTERFERING RNA; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, MOUSE; MTOR PROTEIN, MOUSE; STILBENE DERIVATIVE; TARGET OF RAPAMYCIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL DEATH; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; ENZYME INHIBITION; IN VITRO STUDY; MELANOMA B16; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; GENE SILENCING; GENETICS; MELANOMA, EXPERIMENTAL; METABOLISM; MOUSE; PATHOLOGY; TUMOR CELL LINE;

RICE STRIPE VIRUS;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL DEATH; CELL LINE, TUMOR; CERAMIDES; GENE KNOCKDOWN TECHNIQUES; MELANOMA, EXPERIMENTAL; MICE; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STILBENES; TOR SERINE-THREONINE KINASES;

EID: 84897446670     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.878738     Document Type: Article

References (26)

1. Jang S and Atkins MB: Which drug, and when, for patients with BRAFmutant melanoma Lancet Oncol 14(2), E60-E9, 2013.
2. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al.: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220, 1997. (Pubitemid 127696281)
3. Li G, He S, Chang L, Lu H, Zhang H, and Chiu J: GADD45alpha and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrol. Phytomedicine 18, 704-709, 2011.
4. Cottart CH, Nivet-Antoine V, Laguillier-Morizot C, and Beaudeux JL: Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 54, 7-16, 2010.
5. Sun H, Yu T, and Li JC: Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: more than just AKT inhibition. Cancer Lett 310, 118-128, 2011.
6. Li J, Qin Z, and Liang Z: The prosurvival role of autophagy in Resveratrolinduced cytotoxicity in human U251 glioma cells. BMC Cancer 9, 215, 2009.
7. Filippi-Chiela EC, Villodre ES, Zamin LL, and Lenz G: Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS One6(6), e20849, 2011.
8. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, et al.: Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36, 585-595, 2004. . (Pubitemid 38715985)
9. Fu J, Shao CJ, Chen FR, Ng HK, Chen ZP. Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neuro-Oncology 12, 328-340, 2010.
10. Takeuchi H, Kondo Y, Fujiwara K, Kanzawa T, Aoki H, et al.: Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 65, 3336-3346, 2005. (Pubitemid 40524618)
11. Xing CG, Zhu BS, Liu HH, Yao HH, and Zhang LF: Class I phosphatidylinositol 3-kinase inhibitor LY294002 activates autophagy and induces apoptosis through p53 pathway in gastric cancer cell line SGC7901. Acta Bioch Bioph Sin 40, 194-201, 2008.
12. Coward J, Ambrosini G, Musi E, Truman JP, Haimovitz-Friedman A, et al.: Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway. Autophagy 5, 184-193, 2009.
13. Yu T, Li J, and Sun H: C6 ceramide potentiates curcumin-induced cell death and apoptosis in melanoma cell lines in vitro. Cancer Chemother Pharmacol 66, 999-1003, 2010.
14. Yu T, Li J, Qiu Y, and Sun H: 1-phenyl-2-decanoylamino-3-morpholino-1- propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation. Mol Cell Biochem 361, 47-54, 2012.
15. Gatouillat G, Balasse E, Joseph-Pietras D, Morjani H, and Madoulet C: Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma. J Cell Biochem 110, 893-902, 2010.
16. Niles RM,McFarlandM,Weimer MB, RedkarA, FuYM, et al.: Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett 190, 157-163, 2003. (Pubitemid 36136014)
17. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, et al.: Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120, 237-248, 2005. (Pubitemid 40174766)
18. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, et al.: The role of autophagy during the early neonatal starvation period. Nature 432, 1032-1036, 2004. (Pubitemid 40052234)
19. Guo XL, Li D, Hu F, Song JR, Zhang SS, et al.: Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett 320, 171-179, 2012.
20. Han W, Sun J, Feng L, Wang K, Li D, et al.: Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells. PLoS One 6, e28491, 2011.
21. Voss V, Senft C, Lang V, Ronellenfitsch MW, Steinbach JP, et al.: The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Mol Cancer Res 8, 1002-1016, 2010.
22. Shintani T and Klionsky DJ: Autophagy in health and disease: a doubleedged sword. Science 306, 990-995, 2004. (Pubitemid 39482894)
23. Jiang H, Shang X, Wu H, Gautam SC, Al-Holou S, et al.: Resveratrol downregulates PI3K/Akt/mTORsignaling pathways in human U251 glioma cells. J Exp Ther Oncol 8, 25-33, 2009.
24. Grullich C, Sullards MC, Fuks Z, Merrill AH, Jr., and Kolesnick R: CD95(Fas/APO-1) signals ceramide generation independent of the effector stage of apoptosis. J Biol Chem 275, 8650-8656, 2000. (Pubitemid 30180215)
25. Ji C, Yang B, Yang YL, He SH, Miao DS, et al.: Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition. Oncogene 29, 6557-6568, 2010.
26. Scarlatti F, Bauvy C, Ventruti A, Sala G, Cluzeaud F, et al.: Ceramidemediated macroautophagy involves inhibition of protein kinase B and upregulation of beclin 1. J Biol Chem 279, 18384-18391, 2004. (Pubitemid 38623254)